Institutional investors control 14.50% of the outstanding shares in AZN. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended June 2017, these large investors purchased a net $4.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FISHER ASSET MANAGEMENT LLC Bought 9.2 Million shares of AstraZeneca
PRIMECAP MANAGEMENT CO. Bought 3.6 Million shares of AstraZeneca
CAPITAL BANK & TRUST CO. Bought 2.7 Million shares of AstraZeneca